Panbela Therapeutics Inc (PBLA)
0.41
-0.03
(-6.82%)
USD |
OTCM |
Apr 26, 16:00
Panbela Therapeutics Max Drawdown (5Y): 100.00% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 99.99% |
| September 30, 2023 | 99.99% |
| August 31, 2023 | 99.99% |
| July 31, 2023 | 99.98% |
| June 30, 2023 | 99.98% |
| May 31, 2023 | 99.94% |
| April 30, 2023 | 99.92% |
| March 31, 2023 | 99.89% |
| February 28, 2023 | 99.70% |
| January 31, 2023 | 99.64% |
| December 31, 2022 | 99.27% |
| November 30, 2022 | 99.01% |
| October 31, 2022 | 99.01% |
| September 30, 2022 | 98.48% |
| August 31, 2022 | 97.11% |
| July 31, 2022 | 97.11% |
| June 30, 2022 | 97.11% |
| May 31, 2022 | 97.11% |
| April 30, 2022 | 97.11% |
| March 31, 2022 | 97.11% |
| Date | Value |
|---|---|
| February 28, 2022 | 97.11% |
| January 31, 2022 | 97.11% |
| December 31, 2021 | 97.11% |
| November 30, 2021 | 97.11% |
| October 31, 2021 | 97.11% |
| September 30, 2021 | 97.11% |
| August 31, 2021 | 97.11% |
| July 31, 2021 | 97.11% |
| June 30, 2021 | 97.11% |
| May 31, 2021 | 97.11% |
| April 30, 2021 | 97.11% |
| March 31, 2021 | 97.11% |
| February 28, 2021 | 97.11% |
| January 31, 2021 | 97.11% |
| December 31, 2020 | 97.11% |
| November 30, 2020 | 97.11% |
| October 31, 2020 | 97.11% |
| September 30, 2020 | 97.11% |
| August 31, 2020 | 97.11% |
| July 31, 2020 | 97.11% |
| June 30, 2020 | 97.11% |
| May 31, 2020 | 97.11% |
| April 30, 2020 | 97.11% |
| March 31, 2020 | 97.11% |
| February 29, 2020 | 97.11% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.11%
Minimum
Apr 2019
100.00%
Maximum
Mar 2024
97.94%
Average
97.11%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
| Processa Pharmaceuticals Inc | -- |
| Fate Therapeutics Inc | 98.59% |
| Ardelyx Inc | 95.33% |
| Checkpoint Therapeutics Inc | 97.22% |
| Palisade Bio Inc | 99.99% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -102.12 |
| Beta (5Y) | 0.7778 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 123.7% |
| Historical Sharpe Ratio (5Y) | -0.7432 |
| Historical Sortino (5Y) | -1.150 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 65.97% |